Page 373 - SAHCS HIVMed Journal Vol 20 No 1 2019

Page 12 of 12 Original Research

32. Stoner MCD, Cole SR, Price J, et al. Timing of initiation of antiretroviral therapy 36. Dellicour S, Sevene E, McGready R, et al. First trimester artemisinin derivatives
and risk of preterm birth in studies of HIV-infected pregnant women: The role and quinine treatments and the risk of adverse pregnancy outcomes in Africa
of selection bias. Epidemiology. 2018;29(2):224–229. https://doi.org/10.1097/ and Asia: A meta-analysis of observational studies. PLoS Med. 14(5):e1002290.
EDE.0000000000000772 https://doi.org/10.1371/journal.pmed.1002290
33. Liu KC, Farahani M, Mashamba T, et al. Pregnancy outcomes and birth defects 37. Veroniki AA, Antony J, Straus SE, et al. Comparative safety and effectiveness of
from an antiretroviral drug safety study of women in South Africa and Zambia. perinatal antiretroviral therapies for HIV-infected women and their children:
AIDS. 2014;28(15):2259–2268. https://doi.org/10.1097/QAD.0000000000000394 Systematic review and network meta-analysis including different study designs.
34. Holmes LB. Common malformations. New York: Oxford University Press; 2012. PLoS One. 2018;13(6):e0198447. https://doi.org/10.1371/journal.pone.0198447
35. Macdonald EM, Ng R, Bayoumi AM, et al. Adverse neonatal outcomes among 38. Caniglia EC, Zash R, Jacobson DL, et al. Emulating a target trial of antiretroviral
women living with HIV: A population-based study. J Obstet Gynaecol Can. therapy regimens started before conception and risk of adverse birth outcomes.
2015;37(4):302–309. https://doi.org/10.1016/S1701-2163(15)30279-6 AIDS. 2018;32(1):113–120. https://doi.org/10.1097/QAD.0000000000001673

http://www.sajhivmed.org.za 366 Open Access